The global extensively drug resistant tuberculosis (XDR-TB) treatment market size was valued at USD 947.79 million in 2024 and is expected to reach USD 1,541.69 million by 2032, at a CAGR of 6.27% during the forecast period. Extensively Drug Resistant Tuberculosis (XDR-TB) represents one of the most critical global health challenges, as it is resistant to both first-line and second-line...